Published • loading... • Updated
Faron and City of Hope to develop Phase II trial of bexmarilimab for r/r MDS
Summary by Clinical Trials Arena
1 Articles
1 Articles
Faron and City of Hope to develop Phase II trial of bexmarilimab for r/r MDS
Faron Pharmaceuticals and City of Hope are to co-develop a Phase II for evaluating bexmarilimab in patients with r/r MDS.The post Faron and City of Hope to develop Phase II trial of bexmarilimab for r/r MDS appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
